223 related articles for article (PubMed ID: 29106960)
1. Carnosol-mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis.
Zhao H; Wang Z; Tang F; Zhao Y; Feng D; Li Y; Hu Y; Wang C; Zhou J; Tian X; Yao J
Pharmacol Res; 2018 Feb; 128():327-337. PubMed ID: 29106960
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice.
Li M; Hong W; Hao C; Li L; Wu D; Shen A; Lu J; Zheng Y; Li P; Xu Y
FASEB J; 2018 Jan; 32(1):500-511. PubMed ID: 28970250
[TBL] [Abstract][Full Text] [Related]
3. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.
Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J
J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284
[TBL] [Abstract][Full Text] [Related]
4. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
5. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
6. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
7. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide riboside protects against liver fibrosis induced by CCl
Jiang R; Zhou Y; Wang S; Pang N; Huang Y; Ye M; Wan T; Qiu Y; Pei L; Jiang X; Huang Y; Yang H; Ling W; Li X; Zhang Z; Yang L
Life Sci; 2019 May; 225():20-28. PubMed ID: 30928408
[TBL] [Abstract][Full Text] [Related]
9. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.
Yang JJ; Tao H; Liu LP; Hu W; Deng ZY; Li J
Inflamm Res; 2017 Apr; 66(4):341-352. PubMed ID: 28025657
[TBL] [Abstract][Full Text] [Related]
10. Paeoniflorin promotes PPARγ expression to suppress HSCs activation by inhibiting EZH2-mediated histone H3K27 trimethylation.
Lan T; Li P; Zhang SJ; Liu SY; Zeng XX; Chai F; Tong YH; Mao ZJ; Wang SW
Phytomedicine; 2024 Jun; 128():155477. PubMed ID: 38489890
[TBL] [Abstract][Full Text] [Related]
11. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial-mesenchymal transition.
Sun YL; Bai T; Zhou L; Zhu RT; Wang WJ; Liang RP; Li J; Zhang CX; Gou JJ
J Cell Physiol; 2021 Jun; 236(6):4313-4329. PubMed ID: 33230845
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits hepatic stellate cell activation by regulating autophagy and apoptosis through the SIRT1 and JNK signaling pathways.
Zhang J; Ping J; Jiang N; Xu L
J Food Biochem; 2022 Dec; 46(12):e14463. PubMed ID: 36314441
[TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34b-5p binds enhancer of zeste 2 to inhibit milk fat globule-EGF factor 8 expression, affecting liver fibrosis.
Ma J; Liu Q; Chen M; He B; Li Y; Zhang M; Jiang Y
J Physiol Biochem; 2022 Nov; 78(4):885-895. PubMed ID: 36138295
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Shao J; Bian Y; Fang M; Xu Y
Sci Rep; 2016 Jun; 6():28432. PubMed ID: 27323886
[TBL] [Abstract][Full Text] [Related]
16. CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis.
Cai X; Li Z; Zhang Q; Qu Y; Xu M; Wan X; Lu L
J Cell Mol Med; 2018 Oct; 22(10):5050-5061. PubMed ID: 30106235
[TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cell-specific deletion of SIRT1 exacerbates liver fibrosis in mice.
Li M; Hong W; Hao C; Li L; Xu H; Li P; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3202-3211. PubMed ID: 28919365
[TBL] [Abstract][Full Text] [Related]
18. LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.
Li XJ; Zhou F; Li YJ; Xue XY; Qu JR; Fan GF; Liu J; Sun R; Wu JZ; Zheng Q; Liu RP
Acta Pharmacol Sin; 2023 Dec; 44(12):2479-2491. PubMed ID: 37580495
[TBL] [Abstract][Full Text] [Related]
19. Hesperetin derivative attenuates CCl
Chen X; Li XF; Chen Y; Zhu S; Li HD; Chen SY; Wang JN; Pan XY; Bu FT; Huang C; Li J
Int Immunopharmacol; 2019 Nov; 76():105838. PubMed ID: 31473406
[TBL] [Abstract][Full Text] [Related]
20. Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.
Gu L; Tao X; Xu Y; Han X; Qi Y; Xu L; Yin L; Peng J
Toxicol Appl Pharmacol; 2016 Feb; 292():19-29. PubMed ID: 26747300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
